Epigenetic cancer therapies: DNA methyltransferase inhibitors

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.11, Iss.6, 2002-06, pp. : 747-754

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA Methyltransferase-1 Inhibitors as Epigenetic Therapy for Cancer

Current Cancer Drug Targets, Vol. 13, Iss. 4, 2013-05 ,pp. : 379-399

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment

Current Medicinal Chemistry, Vol. 20, Iss. 2, 2013-01 ,pp. : 167-185

Bentham Science Publishers

Access to resources Recommend Favorite

DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies

By Fahy Jacques Jeltsch Albert Arimondo Paola B

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 12, 2012-12 ,pp. : 1427-1442

Informa Healthcare

Access to resources Recommend Favorite

Development of DNA Methyltransferase Inhibitors for the Treatment of Neoplastic Diseases

Current Medicinal Chemistry, Vol. 16, Iss. 17, 2009-06 ,pp. : 2075-2085

Bentham Science Publishers

Access to resources Recommend Favorite

Utility of DNA Methyltransferase Inhibitors for the Treatment of Myelodysplastic Syndromes

Current Pharmaceutical Design, Vol. 18, Iss. 22, 2012-07 ,pp. : 3190-3197

Bentham Science Publishers

Access to resources Recommend Favorite